US Drug Recall Register
Class II · Moderate risk Terminated Initiated May 1, 2012 (14 years ago)

Octreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.

What was recalled

Octreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in 10 x 1 mL single dose vials per pack, Rx only, Manufactured for: Bedford Laboratories, Bedford, OH 44146; Manufactured by: Ben Venue Laboratories, Inc., Bedford, OH 44146; NDC 55390-160-10; UPC 3 55390-160-10 1.

Recalling firm
Ben Venue Laboratories Inc
NDC code
55390-160-10
Origin
OH, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1377-2012

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Octreotide recalls

See all